Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

prof. dr. R.E.G. Schutgens Full Professor

  • Hematology/Van Creveldclinic

R.E.G. Schutgens

Contact

Research Programs

Biography

Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. He is Chair of the Blood Transfusion Committee and of the Anticoagulation Committee at the UMC Utrecht and secretary of the Dutch Society for Thrombosis and Haemostasis. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Side Activities

  • Advisory Board Member Horizonscan geneesmiddelen ZonMW since 1-10-2018

    Board Member Dutch Society of Haemophilia Treaters since 1-1-2018

    Board Member Dutch Society for Thrombosis and Haemostasis since 1-4-2013

    Steering Committee Member European ADVANCE working group since 18-12-2008

Research Output (138)

Abnormal coagulation parameters are a common non-neuromuscular feature in patients with spinal muscular atrophy

Wijngaarde Camiel A., Huisman Albert, Wadman Renske I., Cuppen Inge, Stam Marloes, Heitink-Pollé Katja M.J., Groen Ewout J.N., Schutgens Roger E.G., Van Der Pol W. Ludo feb 2020, In: Journal of Neurology, Neurosurgery and Psychiatry. 91 , p. 212-214 3 p.

Congenital platelet disorders and health status-related quality of life

Blaauwgeers Maaike W, Kruip Marieke J H A, Beckers Erik A M, Coppens Michiel, Eikenboom Jeroen, van Galen Karin P M, Tamminga Rienk Y J, Urbanus Rolf T, Schutgens Roger E G, jan 2020, In: Research and practice in thrombosis and haemostasis. 4 , p. 100-105 6 p.

Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease:A systematic review

Punt M. C., Waning M. L., Mauser-Bunschoten E. P., Kruip M. J.H.A., Eikenboom J., Nieuwenhuizen L., Makelburg A. B.U., Driessens M. H.E., Duvekot J. J., Peters M., Middeldorp J. M., Bloemenkamp K. W.M., Schutgens R. E.G., Lely A. T., Van Galen K. P.M. 24 okt 2019, In: Blood Reviews. 39 9 p.

Catheter Ablation for Atrial Fibrillation in Patients with Hemophilia or von Willebrand Disease

van der Valk Paul R, Mauser-Bunschoten Eveline P, van der Heijden Jeroen F, Schutgens Roger E G okt 2019, In: TH open : companion journal to thrombosis and haemostasis. 3 , p. e335-e339

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P (R)/Humate P (R) treatment in von Willebrand disease patients:Population pharmacokinetics of FVIII during perioperative Haemate P<sup>®</sup>/Humate P<sup>®</sup> treatment in von Willebrand disease patients

de Jager Nico C.B., Bukkems Laura H., Heijdra Jessica M., Hazendonk Carolien H.C.A.M., Fijnvandraat Karin, Meijer Karina, Eikenboom Jeroen, Laros - van Gorkom Britta A.P., Leebeek Frank W.G., Cnossen Marjon H., Mathôt Ron A.A., Collins P. W., Kruip M. J.H.A., Polinder S., Lock J., van Moort I., Goedhart M. C.H.J., Coppens M., Peters M., Preijers T., Brons P., van der Meer F. J.M., Schutgens R. E.G., Fischer K., Driessens M. H.E., Zwaan C. M., van Vliet I., Liesner R., Chowdary P., Keeling D., 26 sep 2019, In: Journal of Thrombosis and Haemostasis. 18 , p. 295-305 11 p.

The Paediatric Haemophilia Activities List (pedHAL) in routine assessment:changes over time, child-parent agreement and informative domains

Kuijlaars Isolde A.R., van der Net Janjaap, Schutgens Roger E.G., Fischer Kathelijn 16 aug 2019, In: Haemophilia. 25 , p. 953-959 7 p.

An update on the ‘danger theory’ in inhibitor development in hemophilia A

Schep Sarah J, Boes Marianne L, Schutgens Roger E G, van Vulpen Lize F D 5 apr 2019, In: Expert Review of Hematology. 12 , p. 335-344 10 p.

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients

Rab Minke A.E., van Oirschot Brigitte A., Bos Jennifer, Merkx Tesy H., van Wesel Annet C.W., Abdulmalik Osheiza, Safo Martin K., Versluijs Birgitta A., Houwing Maite E., Cnossen Marjon H., Riedl Jurgen, Schutgens Roger E.G., Pasterkamp Gerard, Bartels Marije, van Beers Eduard J., van Wijk Richard 19 feb 2019, In: American Journal of Hematology. 94 , p. 575-584 10 p.

The prevalence and burden of hand and wrist bleeds in von Willebrand disease

van Deukeren Désirée, Mauser-Bunschoten Eveline P, Schutgens Roger E G, Eikenboom Jeroen, Meijer Karina, Fijnvandraat Karin, Laros-van Gorkom Britta A P, Cnossen Marjon, de Meris Joke, van der Bom Johanna G, Leebeek Frank W G, van Galen Karin P M 5 nov 2018, In: Haemophilia. 25 , p. e35-e38

Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery

Preijers T., Hazendonk H. C.A.M., Liesner R., Chowdary P., Driessens M. H.E., Hart D., Keeling D., Laros-van Gorkom B. A.P., van der Meer F. J.M., Meijer K., Fijnvandraat K., Leebeek F. W.G., Collins P. W., Cnossen M. H., Mathôt R. A.A., Schutgens R. E.G., Fischer K., 1 nov 2018, In: Journal of Thrombosis and Haemostasis. 16 , p. 2196 2207 p.

All Research Output (138)
To top